Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients.

MLA

Nyangwara, Vincent Aketch, et al. “Cardiotoxicity and Pharmacogenetics of Doxorubicin in Black Zimbabwean Breast Cancer Patients.” British Journal of Clinical Pharmacology, vol. 90, no. 8, Aug. 2024, pp. 1782–89. EBSCOhost, https://doi.org/10.1111/bcp.15659.

APA

Nyangwara, V. A., Mazhindu, T., Chikwambi, Z., Masimirembwa, C., Campbell, T. B., Borok, M., & Ndlovu, N. (2024). Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients. British Journal of Clinical Pharmacology, 90(8), 1782–1789. https://doi.org/10.1111/bcp.15659

Chicago

Nyangwara, Vincent Aketch, Tinashe Mazhindu, Zedias Chikwambi, Collen Masimirembwa, Thomas B. Campbell, Margaret Borok, and Ntokozo Ndlovu. 2024. “Cardiotoxicity and Pharmacogenetics of Doxorubicin in Black Zimbabwean Breast Cancer Patients.” British Journal of Clinical Pharmacology 90 (8): 1782–89. doi:10.1111/bcp.15659.